|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 28 Jun 2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.6 H | 4 - 6 | % |
| Glucose [Mass/volume] in Blood | 117.6 H | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 7.5 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 1.0 | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 8.7 | 8.4 - 10.3 | mg/dL |
| Sodium [Moles/volume] in Blood | 138.7 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.5 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 109.9 H | 98 - 108 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 23.0 | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 234.1 H | 130 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 196.1 H | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 138.6 H | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 56.2 | 46 - 77 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 3.7 | 0 - 30 | mg/g |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows elevated HbA1c and fasting glucose, indicating suboptimal glycemic control (suggestive of diabetes or prediabetes). Lipid profile reveals high total cholesterol, LDL, and triglycerides, increasing cardiovascular risk. Chloride is mildly elevated; other electrolytes and renal function are within normal limits. Urine microalbumin/creatinine is normal, suggesting no current diabetic nephropathy. Stool occult blood is at the upper normal limit. Recommend clinical correlation and management of hyperglycemia and dyslipidemia. |